{"log_id": 6103914636297131251, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.024593, "average": 0.929778, "min": 0.431519}, "location": {"width": 460, "top": 167, "height": 37, "left": 175}, "words": "切监测。目前尚未对严重功能障碍患者进行研究"}, {"probability": {"variance": 0.013318, "average": 0.941659, "min": 0.535156}, "location": {"width": 817, "top": 197, "height": 46, "left": 177}, "words": "肾功能损害:对轻度肾功能损害患者(肌酐清除率51-80ml分 Cockroft和 Gault,计算公"}, {"probability": {"variance": 0.016335, "average": 0.938994, "min": 0.451648}, "location": {"width": 819, "top": 237, "height": 44, "left": 176}, "words": "式详见下文)不建议调整卡培他滨的起始削量。对中度肾功能损害患者(基线肌酐清除案"}, {"probability": {"variance": 0.007124, "average": 0.966022, "min": 0.588891}, "location": {"width": 815, "top": 277, "height": 45, "left": 180}, "words": "30-50ml/分),当用于单药化疗或与多西紫杉醇联合化疗时,建议卡培他滨起始剂量诚为标"}, {"probability": {"variance": 0.017924, "average": 0.942774, "min": 0.358133}, "location": {"width": 823, "top": 316, "height": 47, "left": 177}, "words": "准剂量的75%从1250mg/m2,每日2次减为950mg/m3天2次)见【药代动力学】:特"}, {"probability": {"variance": 0.011555, "average": 0.959742, "min": 0.461736}, "location": {"width": 819, "top": 356, "height": 45, "left": 180}, "words": "殊人群)。患者出现2级到4级不良事件(见【注意事项】)后相应的剂量调整建议根据表"}, {"probability": {"variance": 0.000131, "average": 0.99483, "min": 0.932146}, "location": {"width": 823, "top": 396, "height": 43, "left": 177}, "words": "3和表4的要求进行。对肾功能中度受损患者起始剂量的调整建议既可应用于卡培他滨单药"}, {"probability": {"variance": 0.003848, "average": 0.979144, "min": 0.706791}, "location": {"width": 455, "top": 442, "height": 36, "left": 182}, "words": "治疗,也可应用于卡培他滨和多西紫杉酵联治疗"}, {"probability": {"variance": 0.002628, "average": 0.963473, "min": 0.863774}, "location": {"width": 200, "top": 487, "height": 25, "left": 182}, "words": " Cockroft和 Gault方程"}, {"probability": {"variance": 0.044232, "average": 0.827642, "min": 0.368263}, "location": {"width": 253, "top": 521, "height": 25, "left": 598}, "words": "(140一年龄岁])美体重[kg)"}, {"probability": {"variance": 0.033305, "average": 0.867349, "min": 0.401155}, "location": {"width": 398, "top": 558, "height": 28, "left": 416}, "words": "男性肌酐清除率(72)(血清配[mg)"}, {"probability": {"variance": 0.002618, "average": 0.970937, "min": 0.806918}, "location": {"width": 345, "top": 595, "height": 32, "left": 423}, "words": "女性肌酐清除率=0.85×男性肌酐清除率"}, {"probability": {"variance": 0.003234, "average": 0.979547, "min": 0.716394}, "location": {"width": 818, "top": 635, "height": 43, "left": 188}, "words": "老年患者:卡培他滨单药治疗时,不需要对起始剂量进行调整。与年轻患者相比,卡培他滨"}, {"probability": {"variance": 0.005767, "average": 0.979527, "min": 0.513671}, "location": {"width": 820, "top": 675, "height": 43, "left": 185}, "words": "在老年患者(>60岁)中的不良反应更为显著。卡培他滨与奥沙利铂联合使用时,老年患者"}, {"probability": {"variance": 0.001269, "average": 0.989624, "min": 0.788181}, "location": {"width": 796, "top": 714, "height": 43, "left": 208}, "words": "≥65岁)与年轻患者相比出现更多的3~4度不良反应以及导致停药的不良反应。医生应"}, {"probability": {"variance": 2.1e-05, "average": 0.996562, "min": 0.985388}, "location": {"width": 356, "top": 763, "height": 32, "left": 187}, "words": "该密切监测卡培他滨对老年患者的作用"}, {"probability": {"variance": 0.00022, "average": 0.992887, "min": 0.937913}, "location": {"width": 777, "top": 793, "height": 42, "left": 230}, "words": "当卡培他滨与多西他赛联合使用时,在60岁及以上的患者中可观察到3度或4度药物"}, {"probability": {"variance": 0.002442, "average": 0.982438, "min": 0.746383}, "location": {"width": 816, "top": 832, "height": 43, "left": 189}, "words": "相关性不良事件的发生率升高。因此,对于60岁及以上接受卡培他滨加多西他赛联合治疗"}, {"probability": {"variance": 0.000265, "average": 0.993733, "min": 0.923943}, "location": {"width": 442, "top": 878, "height": 37, "left": 189}, "words": "的患者,建议将卡培他滨的起始剂量降低至75%"}, {"probability": {"variance": 0.00538, "average": 0.961314, "min": 0.758796}, "location": {"width": 776, "top": 911, "height": 42, "left": 236}, "words": "与顺铂联合应用,卡培他滨的推荐剂量是1000mg/m2,1天2次,治疗2周后停药1"}, {"probability": {"variance": 0.00842, "average": 0.964955, "min": 0.512948}, "location": {"width": 820, "top": 949, "height": 44, "left": 191}, "words": "周。顺铂剂量80mg/m2,于每3周疗程的第1天,静脉滴注,2小时滴完。首剂卡培他滨于"}, {"probability": {"variance": 0.000111, "average": 0.99413, "min": 0.957518}, "location": {"width": 429, "top": 995, "height": 37, "left": 192}, "words": "第一天晚间服用,最后一剂于第15天早晨服用"}, {"probability": {"variance": 0.006129, "average": 0.976391, "min": 0.538014}, "location": {"width": 778, "top": 1027, "height": 43, "left": 235}, "words": "接受卡培他滨和顺铂联合治疗的患者,在给予顺铂前,需按照顺铂的产品说明书给予"}, {"probability": {"variance": 0.003657, "average": 0.960148, "min": 0.818875}, "location": {"width": 209, "top": 1079, "height": 29, "left": 194}, "words": "充分的水化和上吐治疗"}, {"probability": {"variance": 0.000126, "average": 0.994863, "min": 0.936227}, "location": {"width": 775, "top": 1105, "height": 42, "left": 239}, "words": "与顺铂联合,出现了主治医生考虑的并不严重或无生命危险的毒副作用,如脱发、食"}, {"probability": {"variance": 0.00143, "average": 0.989776, "min": 0.771283}, "location": {"width": 816, "top": 1144, "height": 42, "left": 197}, "words": "欲改变、指甲变色等,可以继续按始剂量治疗,而不需减量或中断。如需要进一步关于顺铂"}, {"probability": {"variance": 1.6e-05, "average": 0.997053, "min": 0.984121}, "location": {"width": 273, "top": 1194, "height": 31, "left": 197}, "words": "的资料请查询顺铂说明书信息"}, {"probability": {"variance": 0.000547, "average": 0.982737, "min": 0.930742}, "location": {"width": 212, "top": 1237, "height": 26, "left": 201}, "words": "对于血液毒性剂量调整:"}, {"probability": {"variance": 0.001327, "average": 0.983754, "min": 0.806498}, "location": {"width": 769, "top": 1263, "height": 43, "left": 240}, "words": "如果疗程开始时,患者的绝对中性粒细胞计数(ANC)大于100010,血小板计数大于"}, {"probability": {"variance": 0.00519, "average": 0.98136, "min": 0.535197}, "location": {"width": 808, "top": 1304, "height": 41, "left": 208}, "words": "000010/,可以开始新的3周疗程。否则,治疗需要推迟直到血液指标恢复后。血液毒"}, {"probability": {"variance": 4.3e-05, "average": 0.994631, "min": 0.981977}, "location": {"width": 270, "top": 1353, "height": 29, "left": 201}, "words": "性剂量调整的详细指导见表5"}, {"probability": {"variance": 0.006516, "average": 0.97849, "min": 0.521555}, "location": {"width": 736, "top": 1381, "height": 41, "left": 243}, "words": "表5.卡培他滨(X)联合顺铂(P)在计划治疗期间根据血液毒性进行的剂量调整方案"}, {"probability": {"variance": 0.000912, "average": 0.985463, "min": 0.890687}, "location": {"width": 222, "top": 1434, "height": 24, "left": 207}, "words": "中性粒细胞绝对值ANC计数"}, {"probability": {"variance": 1.1e-05, "average": 0.99665, "min": 0.99073}, "location": {"width": 90, "top": 1430, "height": 22, "left": 565}, "words": "血小板计数"}, {"probability": {"variance": 0.008117, "average": 0.941481, "min": 0.647101}, "location": {"width": 280, "top": 1426, "height": 22, "left": 720}, "words": "卡培他滨和顺铂在治疗重新开始时的"}, {"probability": {"variance": 0.048386, "average": 0.762117, "min": 0.484322}, "location": {"width": 64, "top": 1476, "height": 19, "left": 288}, "words": "(×10°/1)"}, {"probability": {"variance": 0.032935, "average": 0.877904, "min": 0.487559}, "location": {"width": 66, "top": 1470, "height": 19, "left": 577}, "words": "(×10/)"}, {"probability": {"variance": 0.053045, "average": 0.769211, "min": 0.50129}, "location": {"width": 74, "top": 1465, "height": 23, "left": 824}, "words": "剂羅调整"}, {"probability": {"variance": 0, "average": 0.91089, "min": 0.91089}, "location": {"width": 19, "top": 1513, "height": 21, "left": 454}, "words": "和"}, {"probability": {"variance": 0.017273, "average": 0.884356, "min": 0.610752}, "location": {"width": 165, "top": 1504, "height": 20, "left": 769}, "words": "6起始剂量,无鑫延迟"}, {"probability": {"variance": 0.016781, "average": 0.905061, "min": 0.682971}, "location": {"width": 177, "top": 1531, "height": 22, "left": 754}, "words": "%起始削量,无延迟"}], "language": 3}